Front page
Nothing from your lists
What covered companies filed with the SEC, day by day.
Nothing from your lists
+ 6 more
Nothing from your lists
RingCentral, Inc. · “The board of directors has since rescheduled the 2026 Annual Meeting for December 7, 2026, commencing at 9:00 a.m., Pacific time.”¶1
Selectis Health, Inc. · “On October 5, 2026 (the “Closing Date”), pursuant to the Merger Agreement, Merger Sub merged with and into the Company (the “Merger”), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Purchaser and an indirect wholly owned subsidiary of Parent.”¶1
CTT Pharmaceutical Holdings, Inc. · “CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is filing a response from the auditor of our last 8-K.”¶1
Cemtrex Inc · “As a result, the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Nevada Reincorporation”) became effective on October 7, 2026, at 12:01 a.m. Eastern Time (the “Effective Time”).”¶1
Volato Group, Inc. · “On October 8, 2026, Volato Group, Inc. (the “Company”) entered into a Common Stock Purchase Agreement (the “ELOC Purchase Agreement”) and Registration Rights Agreement (the “ELOC Registration Rights Agreement”) with DFU, LLC, a Delaware limited liability company (the “Investor”).”¶1
Nothing from your lists
Nothing from your lists
Nothing from your lists
Nothing from your lists
FTC Solar set November 30, 2026 as the date of its 2026 Annual Meeting of Stockholders, to be held virtually online.¶1
The record date for the 2026 Annual Meeting is October 7, 2026, and the Company reserves the right to change the record date or the meeting date.¶2
Because the meeting date is delayed by more than 60 days from the anniversary of the 2025 Annual Meeting, the deadline in the 2025 proxy statement for stockholder nominations or proposals no longer applies.¶3
The deadline for stockholder proposals and director nominations for the 2026 Annual Meeting is October 19, 2026.¶4¶5
The board of directors rescheduled the 2026 Annual Meeting of Stockholders from November 2, 2026 to December 7, 2026, commencing at 9:00 a.m., Pacific time.¶1
Because the new meeting date is not more than 25 days before the one-year anniversary of the 2025 annual meeting held on December 31, 2025, nomination and proposal deadlines outside Rule 14a-8 reverted to the deadlines in the 2025 proxy statement.¶1
The Rule 14a-8 proposal deadline remains 11:59 p.m., Pacific time, on October 9, 2026, and is not changing due to the rescheduling.¶2
Timely stockholder proposals or director nominations outside Rule 14a-8 must be received between 5:00 p.m., Pacific time, on September 25, 2026 and 5:00 p.m., Pacific time, on October 25, 2026.¶2
Merger Sub merged with and into Selectis Health, Inc. on October 5, 2026, making the Company a wholly owned subsidiary of Purchaser, and each Share was converted into the right to receive $5.75 in cash.¶1¶2
The Company became a borrower under a Credit Agreement with Term Loans in an aggregate principal amount of $18,226,250.00, bearing a fixed rate of 5.0% per annum and maturing on August 28, 2031.¶3¶4
Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as directors, Krystal Eckhart ceased as Interim Chief Financial Officer, and Abraham Schwartz and Zalman Schapiro became the Company's directors and officers.¶5¶6
All outstanding Series A and Series D Convertible Preferred Stock was redeemed, and the Shares will no longer be quoted on the OTCQB market while the Company intends to file a Form 15.¶7¶8
On October 6, 2026, Verde Resources approved the dismissal of J&S Associate PLT as its independent registered public accounting firm, effective immediately.¶1
The board concurrently approved the appointment of MBP Global LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2027, effective immediately.¶1
J&S's audit report for the fiscal years ended June 30, 2026 and 2025 contained no adverse opinion or disclaimer, except a separate Critical Audit Matters section on the Impairment Assessment of Intellectual Properties.¶2¶3
The Company did not consult MBP Global on accounting principles or audit opinions before engaging it.¶4
CTT Pharmaceutical Holdings, Inc. filed a report under Item 4.01, Changes in Registrant's Certifying Accountant, for an earliest event dated October 8, 2026.¶2¶3
The filing includes a response from the auditor of the company's last 8-K, which agrees to what CTT Pharma previously filed, furnished as Exhibit 16.1.¶1¶4
Ryan Khouri, Chief Executive Officer, signed the report on behalf of the company on 10/09/2026.¶5¶6¶7
Profusa engaged WithumSmith+Brown, PC on October 6, 2026 as its independent registered public accounting firm for the fiscal year ending December 31, 2026, following Audit Committee approval on September 30, 2026.¶1¶2
CBIZ's report on the fiscal year ended December 31, 2025 contained an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern.¶3
The filing states there were no disagreements with CBIZ, but it lists material weaknesses in internal control over financial reporting that had not been remediated as of June 30, 2026.¶4
On October 8, 2026, the Board declared a dividend of one stapled contingent value right for each share of common stock outstanding at the close of business on October 19, 2026, under a Stapled Contingent Value Rights Agreement with VStock Transfer, LLC, as rights agent.¶1
Each Stapled CVR entitles its holder to a pro rata share of a CVR Payment equal to 25% of the Net Proceeds from the sale or deemed monetization of the first priority review voucher awarded on or before December 31, 2036, capped at $50 million.¶2¶3
As of the date of the report, (Z)-endoxifen has not been approved by the FDA for any indication and no priority review voucher has been awarded to the Company.¶4
The Board may at any time detach the Stapled CVRs from the Common Stock, and the CVR Agreement does not require the Company to pursue any development or monetization of a voucher.¶5¶6
Cemtrex, Inc. filed a certificate of conversion in Delaware and articles of conversion in Nevada on October 6, 2026, and the reincorporation from Delaware to Nevada became effective October 7, 2026, at 12:01 a.m. Eastern Time.¶1
The reincorporation was a statutory conversion under Section 266 of the Delaware General Corporation Law and NRS 92A.205, approved by the board and by written consent of a majority voting holder; a Schedule 14C was filed September 15, 2026.¶2
At the Effective Time, each outstanding share of common stock, Series C preferred stock, and Series 1 preferred stock, each par value $0.001 per share, automatically converted into one share of the corresponding Nevada class or series.¶3
The common stock continues to trade on The Nasdaq Capital Market under the symbol CETX, and the Series 1 preferred stock continues to be quoted on the OTC market under the symbol CETXP.¶4
On October 8, 2026, Volato Group, Inc. entered into a Common Stock Purchase Agreement and Registration Rights Agreement with DFU, LLC, under which the Company may sell up to $1,000,000,000 of Class A common stock over 36 months.¶1
Each Put Notice may cover up to $6,000,000 of ELOC Shares, with up to two Put Notices per trading day, subject to a Floor Price of $0.21.¶2
As consideration, the Company agreed to issue the Investor 3,646,974 shares of common stock and 13,058 shares of Series B Preferred Stock convertible into an aggregate of 56,528,082 shares of common stock.¶3
The Company filed a Certificate of Designation for the Series B Preferred Stock with the Delaware Secretary of State on October 9, 2026, and the Series B Preferred Stock is convertible only after Stockholder Approval.¶4
The Company agreed to file an initial registration statement covering the resale of the shares by the Investor by November 22, 2026.¶5
Ranger Energy Services completed on October 8, 2026 its acquisition of certain assets of STEP Energy Services' coiled tubing, fluid and nitrogen pumping, and related well services business in the United States.¶1
The Company acquired certain coiled tubing units and related equipment, other operating assets, and certain rights under leases, and assumed certain facility, vehicle and equipment lease obligations.¶2
The aggregate consideration was approximately $27.5 million, consisting of $22.5 million in cash and 307,503 shares of Class A Common Stock valued at $5.0 million.¶3
On October 8, 2026, TruGolf Holdings completed its acquisition of Polymath Research Inc. through an amalgamation, and Polymath became a wholly owned subsidiary of the Company.¶1¶2
Polymath shareholders received 257,494 shares of Class A common stock and 136,956 shares of Series C convertible preferred stock at the effective time of the amalgamation.¶3¶4
Certain holders of Series B preferred warrants agreed to exercise warrants to purchase 3,278 shares of Series B preferred stock for an aggregate exercise price of $2,950,000 in exchange for additional warrants to purchase 3,000 shares.¶5
Humphrey Polanen resigned from the Board of Directors on October 8, 2026, and David Hackett was appointed to the Board on the same date.¶6¶7¶8
Natalie Hirsch was appointed Chief Financial Officer and Chief Operating Officer effective October 8, 2026, with a base salary of $275,000 per annum under an Employment Agreement.¶8¶9
On October 6, 2026, Ashford Philly LP completed the sale of the Embassy Suites Philadelphia Hotel in Philadelphia, Pennsylvania to SSN 9000 Bartram Road LLC for approximately $26.0 million in cash, subject to customary pro-rations and adjustments.¶1
The exhibit describes the hotel as the 263-room Embassy Suites Philadelphia Airport, with total consideration of approximately $25.2 million in cash, net of selling expenses.¶2
The Company paid approximately $24.6 million to the mortgage lender, and the mortgage loan is secured by 12 hotels including this property.¶2
The unaudited pro forma financial information removes the hotel and states that the pro forma gain and related tax effects from the disposition are preliminary.¶3¶4
On October 6, 2026, the Company completed its acquisition of all issued and outstanding membership interests of GLS from the Sole Member, and GLS became a wholly owned subsidiary of the Company.¶1¶2¶3
The Company paid the Sole Member $2,000,000 in cash and issued 25,000,000 shares of common stock, with a stated $2,250,000 stock value, plus an additional $135,000 paid to the Sole Member.¶2¶4
At the Closing the Company paid Canton $1,000,000 and GLS paid $125,000 as a mandatory prepayment on the Canton Seller Note, and the Company became its sole maker, obligor and guarantor.¶5
Vincent LoPriore, Gary Stetz, Sireesh Appajosyula and Chase LoPriore, directors and officers of GLS, recused themselves, and the disinterested directors approved the transaction, which a Ryan Valuation Services fairness opinion supports.¶6
On October 9, 2026, the Board appointed Gary Stetz as Chief Financial Officer and Sireesh Appajosyula as Chief Executive Officer, each effective October 9, 2026.¶7
